Legal Opinion
Eurand, Inc. v. Mylan Pharmaceuticals Inc.
Court of Appeals for the Federal Circuit
Decided April 16, 2012No. Nos. 2011-1399, 2011-1409PublishedCited by 220 opinions
1Opinion of the Court
O’MALLEY, Circuit Judge.
After a bench trial, the U.S. District Court for the District of Delaware found U.S. Patent Nos. 7,387,793 and 7,544,372 invalid as obvious. Case No.2011-1409 is an appeal from that judgment. We reverse and vacate the district court’s judgment of invalidity because the district court erred when it declared the patents in suit invalid as obvious. Specifically, by failing to consider the lack of a known pharmacokinetic/pharmacodynamic relationship for the claimed drug formulation, the trial court erred when it assessed the importance of the teachings of the prior art to…
2Cases cited51 opinions
- McDonnell Douglas Corp. v. GreenSupreme Court of the United States · 1973
- Texas Department of Community Affairs v. BurdineSupreme Court of the United States · 1981
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
46 more not listed; retrieve them via the Exa API.
3Cited by220 opinions
- Wbip, LLC v. Kohler Co.Court of Appeals for the Federal Circuit · 2016
- Arctic Cat Inc. v. Bombardier Recreational Products Inc.Court of Appeals for the Federal Circuit · 2017
- Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd.Court of Appeals for the Federal Circuit · 2016
- Power Integrations, Inc. v. Fairchild Semiconductor International, Inc.Court of Appeals for the Federal Circuit · 2013
- Apple Inc. v. Samsung Electronics Co., Ltd.Court of Appeals for the Federal Circuit · 2016
215 more not listed; retrieve them via the Exa API.